Literature DB >> 29039212

Propagation and titration of infectious bursal disease virus, including non-cell-culture-adapted strains, using ex vivo-stimulated chicken bursal cells.

Sébastien Mathieu Soubies1, Céline Courtillon1, Mouna Abed2, Michel Amelot1, Alassane Keita1, Andrew Broadbent3, Sonja Härtle4, Bernd Kaspers4, Nicolas Eterradossi1.   

Abstract

Infectious bursal disease virus (IBDV) is a Birnaviridae family member of economic importance for poultry. This virus infects and destroys developing B lymphocytes in the cloacal bursa, resulting in a potentially fatal or immunosuppressive disease in chickens. Naturally occurring viruses and many vaccine strains are not able to grow in in vitro systems without prior adaptation, which often affects viral properties such as virulence. Primary bursal cells, which are the main target cells of lymphotropic IBDV in vivo, may represent an attractive system for the study of IBDV. Unfortunately, bursal cells isolated from bursal follicles undergo apoptosis within hours following their isolation. Here, we demonstrate that ex vivo stimulation of bursal cells with phorbol 12-myristate 13-acetate maintains their viability long enough to allow IBDV replication to high titres. A wide range of field-derived or vaccine serotype 1 IBDV strains could be titrated in these phorbol 12-myristate 13-acetate -stimulated bursal cells and furthermore were permissive for replication of non-cell-culture-adapted viruses. These cells also supported multistep replication experiments and flow cytometry analysis of infection. Ex vivo-stimulated bursal cells therefore offer a promising tool in the study of IBDV.

Entities:  

Keywords:  Gumboro disease; chicken; infectious bursal disease virus; primary bursal cells; titration

Mesh:

Substances:

Year:  2017        PMID: 29039212     DOI: 10.1080/03079457.2017.1393044

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  5 in total

1.  Blood B Cell Depletion Reflects Immunosuppression Induced by Live-Attenuated Infectious Bursal Disease Vaccines.

Authors:  Céline Courtillon; Chantal Allée; Michel Amelot; Alassane Keita; Stéphanie Bougeard; Sonja Härtle; Jean-Claude Rouby; Nicolas Eterradossi; Sebastien Mathieu Soubies
Journal:  Front Vet Sci       Date:  2022-04-25

2.  Evaluating the Breadth of Neutralizing Antibody Responses Elicited by Infectious Bursal Disease Virus Genogroup A1 Strains Using a Novel Chicken B-Cell Rescue System and Neutralization Assay.

Authors:  Vishwanatha R A P Reddy; Salik Nazki; Andrew J Brodrick; Amin Asfor; Joanna Urbaniec; Yasmin Morris; Andrew J Broadbent
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

3.  Genome Evolution of Two Genetically Homogeneous Infectious Bursal Disease Virus Strains During Passages in vitro and ex vivo in the Presence of a Mutagenic Nucleoside Analog.

Authors:  Liliana L Cubas-Gaona; Alexandre Flageul; Céline Courtillon; Francois-Xavier Briand; Maud Contrant; Stephanie Bougeard; Pierrick Lucas; Hélène Quenault; Aurélie Leroux; Alassane Keita; Michel Amelot; Béatrice Grasland; Yannick Blanchard; Nicolas Eterradossi; Paul Alun Brown; Sébastien Mathieu Soubies
Journal:  Front Microbiol       Date:  2021-06-11       Impact factor: 5.640

4.  An Ex Vivo Chicken Primary Bursal-cell Culture Model to Study Infectious Bursal Disease Virus Pathogenesis.

Authors:  Katherine L Dulwich; Amin S Asfor; Alice G Gray; Venugopal Nair; Andrew J Broadbent
Journal:  J Vis Exp       Date:  2018-10-04       Impact factor: 1.355

5.  Ex vivo rescue of recombinant very virulent IBDV using a RNA polymerase II driven system and primary chicken bursal cells.

Authors:  Liliana L Cubas-Gaona; Romane Trombetta; Céline Courtillon; Kai Li; Xiaole Qi; Xiaomei Wang; Sofiane Lotmani; Alassane Keita; Michel Amelot; Nicolas Eterradossi; Sébastien Mathieu Soubies
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.